Plain-English translation of NCT06645470 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether exercise can help improve the benefits of weight-loss medications like semaglutide or tirzepatide. Researchers want to see if adding aerobic training (like walking or cycling) or resistance training (like weight lifting) to your regular treatment makes a bigger difference in your muscle mass, strength, and overall fitness compared to medication alone.
Weight-loss medications are effective, but researchers don't yet know whether combining them with exercise helps people keep more muscle while losing weight—or whether exercise provides additional health benefits like better heart health and strength.
You likely qualify if…
You likely don't qualify if…
You will be in the study for 6 months. You'll continue taking your weight-loss medication as prescribed. Depending on which group you're randomly assigned to, you may receive supervised aerobic exercise sessions, supervised strength training sessions, or standard care with brief check-ins from the research team at weeks 6, 12, and 18. The study will measure changes in your muscle mass, strength, fitness, blood pressure, and overall quality of life through tests and assessments.
AI-generated summary from trial data · Aug 6, 2026 · Not medical advice
United States